Evaxion A/S (EVAX) — Institutional Holders, Q2 2026
20 institutional investment managers reported a EVAX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $4.9M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
EVAX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- MerckNew · +1,214,126 sh+$3.8M
- J. Safra Sarasin Holding AGNew · +22,896 sh+$71.0K
- JANE STREET GROUPNew · +20,581 sh+$63.8K
- CITADEL ADVISORSAdded · +18,811 sh+$58.3K
- UBS Group AGNew · +6,275 sh+$19.5K
Biggest sellers
- XTX Topco LtdTrimmed · -9,154 sh-$28.4K
- RENAISSANCE TECHNOLOGIESTrimmed · -5,425 sh-$16.8K
- Stonepine Capital ManagementTrimmed · -2,151 sh-$6.7K
- GAMMA InvestingTrimmed · -586 sh-$1.8K
- SmartHarvest PortfoliosTrimmed · -348 sh-$1.1K
EVAX 13F holders ranked 1–20 of 20
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Merck#1 · 1,214,126 sh | 1,214,126 | $3.8M | 0.71% | New |
| 2 | Ikarian Capital#2 · 74,698 sh | 74,698 | $231.6K | 0.02% | 0.0% |
| 3 | Rathbones Group PLC#3 · 45,723 sh | 45,723 | $141.7K | <0.01% | 0.0% |
| 4 | CITADEL ADVISORS#4 · 36,584 sh | 36,584 | $113.4K | 0.00% | +105.8% |
| 5 | RENAISSANCE TECHNOLOGIES#5 · 33,800 sh | 33,800 | $104.8K | <0.01% | -13.8% |
| 6 | Annis Gardner Whiting Capital Advisors#6 · 30,000 sh | 30,000 | $93.0K | 0.01% | 0.0% |
| 7 | J. Safra Sarasin Holding AG#7 · 22,896 sh | 22,896 | $71.0K | — | New |
| 8 | RHUMBLINE ADVISERS#8 · 21,849 sh | 21,849 | $67.7K | <0.01% | +0.9% |
| 9 | JANE STREET GROUP#9 · 20,581 sh | 20,581 | $63.8K | 0.00% | New |
| 10 | BOOTHBAY FUND MANAGEMENT#10 · 18,426 sh | 18,426 | $57.1K | <0.01% | 0.0% |
| 11 | Stonepine Capital Management#11 · 17,562 sh | 17,562 | $54.4K | 0.03% | -10.9% |
| 12 | SmartHarvest Portfolios#12 · 13,460 sh | 13,460 | $41.7K | — | -2.5% |
| 13 | XTX Topco Ltd#13 · 12,899 sh | 12,899 | $40.0K | <0.01% | -41.5% |
| 14 | WESBANCO BANK#14 · 10,000 sh | 10,000 | $31.0K | <0.01% | 0.0% |
| 15 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT#15 · 8,000 sh | 8,000 | $24.8K | 0.00% | 0.0% |
| 16 | UBS Group AG#16 · 6,275 sh | 6,275 | $19.5K | 0.00% | New |
| 17 | GAMMA Investing#17 · 4,612 sh | 4,612 | $14.3K | — | -11.3% |
| 18 | Integrated Wealth Concepts#18 · 642 sh | 642 | $2.0K | 0.00% | New |
| 19 | SBI Securities , Ltd.#19 · 62 sh | 62 | $192.00 | — | 0.0% |
| 20 | BESSEMER GROUP#20 · 18 sh | 18 | $0.00 | 0.00% | 0.0% |
Funds that sold out of EVAX in Q2 2026 (1)
Held EVAX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| EverSource Wealth Advisors720 sh | 720 | $11.7K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.